Oxidation of alpha1-proteinase inhibitor by the myeloperoxidase-hydrogen peroxidase system promotes binding to immunoglobulin A.
Affiliation
Department of Haemopoeitic Cell and Gene Therapy, Paterson Institute for Cancer Research, Christie Hospital, Wilmslow Road, Manchester, M20 4BX, United Kingdom.Issue Date
1999-02-24
Metadata
Show full item recordAbstract
We have demonstrated previously that patients with rheumatoid arthritis (RA) show an increase in serum and synovial fluid levels of complexes between alpha1-proteinase inhibitor (alpha1PI) and IgA. These are believed to form through disulfide binding between the Cys232 residue on alpha1PI and the penultimate cysteine residue (Cys471) of the IgA alpha chain. The mechanism for this has not been elucidated. We show here that alpha1PI oxidized by the myeloperoxidase-hydrogen peroxide (MPO-H2O2) system promotes the formation of IgA-alpha1PI complexes when incubated with IgA and that such complexes have no inhibitory activity against porcine pancreatic elastase (PPE). The activity of alpha1PI was considerably reduced also in IgA-alpha1PI complexes isolated from serum of an RA patient. We suggest that formation of IgA-alpha1PI complexes in inflammation may involve oxidation of alpha1PI, and as a consequence the alpha1PI in such complexes has reduced elastase inhibitory activity.Citation
Oxidation of alpha1-proteinase inhibitor by the myeloperoxidase-hydrogen peroxidase system promotes binding to immunoglobulin A. 1999, 255 (3):562-7 Biochem. Biophys. Res. Commun.Journal
Biochemical and Biophysical Research CommunicationsDOI
10.1006/bbrc.1999.0247PubMed ID
10049750Type
ArticleLanguage
enISSN
0006-291Xae974a485f413a2113503eed53cd6c53
10.1006/bbrc.1999.0247
Scopus Count
Collections
Related articles
- Serum complexes of immunoglobulin A-alpha1 proteinase inhibitor in rheumatoid arthritis: association with current cigarette smoking and disease activity.
- Authors: Hutchinson D, O'Leary C, Nixon NB, Mattey DL
- Issue date: 2002 May-Jun
- Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.
- Authors: Bristow CL, Di Meo F, Arnold RR
- Issue date: 1998 Dec
- Polymorphonuclear elastase-alpha1-proteinase inhibitor (elastase-alpha1 antitrypsin) in patients with rheumatic diseases: influence of disease activity.
- Authors: Beyeler C, Banks RE, Bird HA
- Issue date: 2000 Jan
- Measurement of both native and inactivated forms of alpha1 proteinase inhibitor in human inflammatory extracellular fluids.
- Authors: Petropoulou P, Zhang Z, Curtis MA, Johnson NW, Hughes FJ, Winyard PG
- Issue date: 2003 Sep
- Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
- Authors: Adam C, Bieth JG
- Issue date: 1996 May 6